Diagnostic Performance of Fecal Immunochemical Test and Sigmoidoscopy for Advanced Right-Sided Colorectal Neoplasms

Digestive Diseases and Sciences

Volumn 60, Issue 5, 2015, Pages 1424-1432

  Castro, Inés ^a   Estevez, Pamela ^b,c   Cubiella, Joaquín ^a,f   Hernandez, Vicent ^b,c   González Mao, Carmen ^b,c   Rivera, Concepción ^a   Iglesias, Felipe ^b   Cid, Lucía ^b,c   Soto, Santiago ^a   de Castro, Luisa ^b,c   Vega, Pablo ^a   Hermo, Jose Antonio ^b   Macenlle, Ramiro ^a   Martínez, Alfonso ^b,c   Cid, Estela ^a   Gil, Inés ^d   Larzabal, Mikel ^d   Bujanda, Luis ^d   Castells, Antoni ^e  

^a Complexo Hospitalario Universitario de Ourense ^*  (Spain)

^b UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^c IBIV Institute of Biomedical Research of Vigo   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f Departments of Pathology and Gastroenterology   (Spain)

Author keywords

Colonoscopy; Colorectal cancer screening; Colorectal neoplasm; Fecal immunochemical test; Sigmoidoscopy

Indexed keywords

AGED; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; MIDDLE AGED; MULTICENTER STUDY; OCCULT BLOOD; PATHOLOGY; PATIENT REFERRAL; PREDICTIVE VALUE; PROGNOSIS; SIGMOIDOSCOPY; SPAIN;

AGED; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERRAL AND CONSULTATION; SIGMOIDOSCOPY; SPAIN;

EID: 84936988796     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3434-6     Document Type: Article

References (35)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128.
2. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103:1541–1549.
3. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.
4. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–1633.
5. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33:88–100.
6. Holme O, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane database Syst Rev. 2013;9:CD009259.
7. Sharp L, Tilson L, Whyte S, et al. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based fecal occult blood testing, fecal immunochemical testing and flexible sigmoidoscopy. Br J Cancer. 2012;106:805–816.
8. Elmunzer BJ, Hayward RA, Schoenfeld PS, et al. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9:e1001352.
9. Imperiale TF, Wagner DR, Lin CY, Larkin, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169–174.
10. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial–SCORE. J Natl Cancer Inst. 2011;103:1310–1322.
11. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345–2357.
12. Park DI, Ryu S, Kim Y-H, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105:2017–2025.
13. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical fecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59:62–68.
14. Haug U, Knudsen AB, Brenner H, et al. Is fecal occult blood testing more sensitive for left-versus right-sided colorectal neoplasia? A systematic literature review. Expert Rev Mol Diagn. 2011;11:605–616.
15. Segnan N, Senore C, Andreoni B, et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst. 2005;97:347–357.
16. Segnan N, Senore C, Andreoni B, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132:2304–2312.
17. Littlejohn C, Hilton S, Macfarlane GJ, et al. Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer. Br J Surg. 2012;99:1488–1500.
18. Hernandez V, Cubiella J, Gonzalez-Mao MC, et al. Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World J Gastroenterol. 2014;20:1038–1047.
19. Castro I, Cubiella J, Rivera C, et al. Fecal immunochemical test accuracy in familial risk colorectal cancer screening. Int J Cancer. 2014;134:367–375.
20. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697–706.
21. Salas D. Situación de los programas de cribado de cáncer colorrectal en España. Situación 2006–14. http://www.programascancerdemama.org/images/archivos/colorrectal/situacion/Implantacion%20CCCR%20en%20Espa%C3%B1a%202014.pdf. Accessed Nov 2014.
22. Jover R, Herráiz M, Alarcón O, et al. Clinical practice guidelines: quality of colonoscopy in colorectal cancer screening. Endoscopy. 2012;44:444–451.
23. Bretthauer M, Gondal G, Larsen K, et al. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol. 2002;37:568–573.
24. Castells A, Bessa X, Quintero E, et al. Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. J Natl Cancer Inst. 2013;105:878–886.
25. Castells A, Quintero E, Alvarez C, el al. Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests. Clin Gastroenterol Hepatol. 2014;12:1708–1716.
26. Cubiella J, Salve M, Díaz-Ondina M, et al. Diagnostic accuracy of fecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria. Colorectal Dis. 2014;16:O273–O282.
27. Gonzalo V, Lozano JJ, Muñoz J, et al. Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. PLoS One. 2010;5:e8777.
28. Ogino S, Kawasaki T, Kirkner GJ, et al. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Gut. 2007;56:1564–1571.
29. Taupin DR, Corbett M. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust. 2006;185:238–239.
30. Gondal G, Grotmol T, Hofstad B, et al. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50–64 years. Scand J Gastroenterol. 2003;38:635–642.
31. Hoff G, Grotmol T, Skovlund E, et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009;338:b1846.
32. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:659–669.
33. Kato J, Morikawa T, Kuriyama M, et al. Combination of sigmoidoscopy and a fecal immunochemical test to detect proximal colon neoplasia. Clin Gastroenterol Hepatol. 2009;7:1341–1346.
34. Wang YR, Cangemi JR, Loftus EV, et al. Increased odds of interval distal colorectal cancer after flexible sigmoidoscopy compared with colonoscopy in older patients in the United States: a population-based analysis of the SEER-Medicare linked database, 2001–2005. Mayo Clin Proc. 2013;88:471–478.
35. Imperiale TF, Glowinski EA, Lin-Cooper C, et al. Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia. Am J Med. 2012;125:1181–1187.